Skip to main content

Table 4 Predicted once daily doses of marbofloxacin at steady state in pigs of three ages (weeks): 27 (A), 16 (B) and 12 (C)a

From: Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling

 

Predicted daily doses

(mg/kg)

Target Attainment Rate

50%

90%

A.

  P. multocida

Bacteriostatic

0.08

0.19

Bactericidal

0.18

0.43

Virtual eradication

0.28

0.67

  A. Pleuropneumoniae

Bacteriostatic

0.07

0.17

Bactericidal

0.12

0.29

4log10 reduction

0.15

0.36

B.

  P. multocida

Bacteriostatic

0.09

0.21

Bactericidal

0.20

0.45

Virtual eradication

0.32

0.72

  A. pleuropneumoniae

Bacteriostatic

0.08

0.17

Bactericidal

0.13

0.30

4log10 reduction

0.17

0.37

C.

  P. multocida

Bacteriostatic

0.13

0.28

Bactericidal

0.28

0.59

Virtual eradication

0.45

0.94

  A. pleuropneumoniae

Bacteriostatic

0.10

0.22

Bactericidal

0.18

0.39

4log10 reduction

0.22

0.48

  1. aMonte Carlo simulation to achieve 50 and 90% target attainment rates at steady state for three levels of bacterial kill